D-vitamin And Graves' Disease; Morbidity And Relapse Reduction (DAGMAR)
The DAGMAR Study. D-vitamin And Graves' Disease; Morbidity And Relapse Reduction: A Randomised, Clinical Trial.
Sponsor: Aarhus University Hospital
A NA clinical study on Graves' Disease, this trial is completed. The trial is conducted by Aarhus University Hospital and has accumulated 9 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2022 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Nov 2021 — Sep 2022 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Jan 2021 — Nov 2021 [monthly]
Active Not Recruiting NA
-
Nov 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Nov 2019 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Mar 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aarhus University Hospital
- Herning Hospital
- Randers Regional Hospital
- Regional Hospital Holstebro
- Regionshospitalet Horsens
- Regionshospitalet Silkeborg
- Regionshospitalet Viborg, Skive
- University of Aarhus
For direct contact, visit the study record on ClinicalTrials.gov .